DeepMind spin-off steps up effort to use AI to create new drugs
Isomorphic Labs poaches pharmaceutical talent as it moves closer to securing first commercial deal.
Isomorphic is currently in talks with major pharmaceutical companies and is expected to announce a deal in the next few months, according to two people familiar with the plans.



